Ferdinand C Breedveld, MD
Professor of Rheumatology, Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands
Charles Campbell, MD
Director of the CCU and Inpatient Cardiovascular Services, Assistant Professor of Medicine, Division of Cardiology, The Linda and Jack Gill Heart Institute, University of Kentucky, Lexington, KY, USA
Fares S Haddad, BSc MCh (Orth) FRCS (Orth) FFSEM
Consultant Orthopaedic Surgeon; Divisional Clinical Director – Surgical Specialties, University College Hospital; Director – Institute of Sport, Exercise, and Health, Division of Surgery and Interventional Science, University College London, London, UK
Neil Haldar MBBS, MD, FRCS (UROL)
Consultant Urologist, Department of Urology, Wycombe General Hospital, High Wycombe, UK
Stephen B Hanauer, MD
Joseph B Kirsner Professor of Medicine & Clinical Pharmacology, Chief, Section of Gastroenterology, Hepatology and Nutrition, University of Chicago, Chicago, IL, USA
David Hopkins, FRCP
Clinical Director, Division of Ambulatory Care & Local Networks King’s College Hospital NHS Foundation Trust; Honorary Senior Lecturer King's College London School of Medicine, London, UK
James Larkin, MD, MRCP, PhD
Consultant Medical Oncologist, Royal Marsden Hospital, London, UK
John R Perfect, MD
Division of Infectious Diseases Director, Mycology Research Unit, Duke University Medical Center, Durham, NC, USA
Jack Satsangi, DPhil, FRCP, FMedSci, FRSE
Professor of Gastroenterology, Centre for Molecular Medicine, The University of Edinburgh, Western General Hospital, Edinburgh, UK
Sarah Wakelin, BSc, MBBS, FRCP
Consultant Dermatologist, St Mary’s Hospital, London, UK
Joel Yager, MD
Professor of Psychiatry, University of Colorado, Denver School of Medicine, Denver, CO, USA |
|
Speaker fees: Abbott.
No relevant financial interests to disclose.
Lecture fees: GlaxoSmithKline, Astellas, Pfizer.
Consultant: Abbott, Alevan, Amgen, Asahi, Astra Zeneca, Bristol Myers Squibb, Centocor, Chemocentryx, Elan, Ferring, Genentech, GSK, McNeil PPC, Millennium/Takeda, Novartis, Otsuka, Procter & Gamble/Warner Chilcott, Prometheus, Salix, Shire, Therakos, UCB Pharma.
Speaker fees: Medtronic, Novo Nordisk, Lilly UK, Bristol Myers Squibb and Astra Zeneca.
Fees for attending advisory board meetings: Novo Nordisk.
Honoraria: Pfizer, BMS, Novartis, GlaxoSmithKline.
Honoraria, research grants and consultancy fees: Pfizer, Merck (Schering-Plough) and Astellas, F2G and Viamet.
Lecture fees: Ferring, Shire
Travel expenses: Warner Chilcott
Research funding: Genentech, Schering-Plough
Honoraria/consultation fees:
- Journal Watch for Psychiatry (Massachusetts Medical Society) – Associate Editor
- Eating Disorders Review (Gurze Press) – Editor in Chief
- UpToDate – Section Editor
- TerraNova Learning Systems – Consultant
|